Therapeutic targets for lung cancer: genome-wide Mendelian randomization and colocalization analyses
Our findings contribute to precision medicine by identifying druggable targets that may be exploited for subtype-specific lung cancer therapies.
Authors
- Wenjun Song (ORCID: https://orcid.org/0000-0002-0165-7894)
- Yi Luan (ORCID: https://orcid.org/0000-0002-2511-0359)
- Changwen Zhao (ORCID: https://orcid.org/0000-0002-9929-1826)
- Wenjian Wang (ORCID: https://orcid.org/0009-0004-1813-5269)
- Hua He (ORCID: https://orcid.org/0009-0003-2585-7684)
- Taijiao Jiang (ORCID: https://orcid.org/0000-0002-6071-0122)
- Chaohui Duan
- Qing Xin (ORCID: https://orcid.org/0009-0002-2749-9756)
- Kaixuan Zheng
- Desheng Xian
Institutions
- Sun Yat-sen University (CN)
- Sichuan University (CN)
- ShanghaiTech University (CN)
- West China Hospital of Sichuan University (CN)
- Sun Yat-sen Memorial Hospital (CN)
- First Affiliated Hospital of Guangzhou Medical University (CN)
- State Key Laboratory of Respiratory Disease (CN)
- Beijing University of Chemical Technology (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-10-28
- DOI
- https://doi.org/10.3389/fphar.2024.1441233
- Citations
- 6
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- National Natural Science Foundation of China